tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CapsoVision Appoints David Garcia as Finance VP

Story Highlights
CapsoVision Appoints David Garcia as Finance VP

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from CapsoVision, Inc. ( (CV) ) is now available.

On November 3, 2025, CapsoVision, Inc. announced the appointment of David Garcia as its Senior Vice President of Finance, who will also serve as the principal financial officer and principal accounting officer. Mr. Garcia brings over 20 years of financial leadership experience, having previously worked at Matterport, Inc., View, Inc., Intelepeer Cloud Communications, and Align Technology. His appointment is seen as a strategic move to support CapsoVision’s growth and development pipeline, leveraging his expertise in financial management and capital markets.

The most recent analyst rating on (CV) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on CapsoVision, Inc. stock, see the CV Stock Forecast page.

Spark’s Take on CV Stock

According to Spark, TipRanks’ AI Analyst, CV is a Neutral.

CapsoVision, Inc. has a low overall stock score primarily due to its poor financial performance, which is a significant concern. The technical analysis provides some positive momentum, but the lack of valuation data limits a comprehensive assessment. The absence of earnings call and corporate events data further constrains the evaluation.

To see Spark’s full report on CV stock, click here.

More about CapsoVision, Inc.

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and diagnosis of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon™ with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection.

Average Trading Volume: 38,056

Current Market Cap: $228.3M

See more data about CV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1